ContractSubscription Agreement • November 4th, 2016 • OWC Pharmaceutical Research Corp. • Surgical & medical instruments & apparatus • Delaware
THIS SUBSCRIPTION AGREEMENT RELATES TO AN OFFERING OF UNITS (THE "UNIT OFFERING"), EACH UNIT COMPRISED OF ONE (1) SHARE OF COMMON STOCK (THE "SHARES") AND ONE (1) CLASS B COMMNON STOCK PURCHASE WARRANT (THE "CLASS B WARRANT"). THE UNIT OFFERING IS BEING IN AN OFFSHORE TRANSACTION TO PERSONS WHO ARE NOT U.S. PERSONS (AS DEFINED HEREIN) PURSUANT TO REGULATION S PROMULGATED BY THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION (THE "SEC") UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "ACT").
MEMORANDUM OF UNDERSTANDINGMemorandum of Understanding • November 4th, 2016 • OWC Pharmaceutical Research Corp. • Surgical & medical instruments & apparatus • New York
THIS MEMORANDUM OF UNDERSTANDING ("JV/MOU") is entered into on the date set forth on the signature page hereof. BETWEEN: One World Cannabis Ltd. ("OWC"), a legal entity organized under the laws of the State of Israel, having a place of business at 22, Shacham Street, Petach Tikva, Israel, herein acting and represented by Ziv Turner, its Chief Operating Officer, duly authorized for the purposes hereof as he so declares; AND: Michepro Holding Ltd, a legal entity constituted under the laws of the State of Cyprus, having a place of business in Nicosia ("EU Partner"); herein acting and represented by Michael A Barth, its Director, duly authorized for the purposes hereof as he so declares. WHICH PARTIES DECLARE THE FOLLOWING: WHEREAS, OWC is a wholly-owned Israeli subsidiary of OWC Pharmaceutical Research Corp., a public company organized under the laws of the State of Delaware (OTCQB: OWCP) ("OWCP"), is focused on discovering, developing and commercializing cannabis-based novel therap
